Publication | Closed Access

Influence of the organic anion-transporting polypeptide 1B1 (OATP1B1) polymorphisms on irinotecan-pharmacokinetics and clinical outcome of patients with advanced non-small cell lung cancer

OncologyOncogenic AgentMedicineBronchial NeoplasmCancer TreatmentClinical OutcomePharmacologyRadiation OncologyLung CancerCancer Research